iPath Pure Beta S&P GSCI-Weighted ETN
SBV
SBV was delisted on the 3rd of April, 2018.
1 hedge funds and large institutions have $35K invested in iPath Pure Beta S&P GSCI-Weighted ETN in 2014 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $26K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Tower Research Capital (TRC)
New York
|
-$26K |
SBV Hedge Fund Activity: Q2 2014 in Review
1 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta S&P GSCI-Weighted ETN (SBV) for Q2 2014, worth a combined $35K — down 42% from $60K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of SBV and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $26K sold.
- 1 institutional investor held iPath Pure Beta S&P GSCI-Weighted ETN (SBV) as of Q2 2014, down from 2 in Q1 2014.
- Funds reported $35K of iPath Pure Beta S&P GSCI-Weighted ETN stock for Q2 2014, down 42% quarter-over-quarter.
- 0 funds opened new iPath Pure Beta S&P GSCI-Weighted ETN positions in Q2 2014 and 1 closed out, a net change of -1 holder.
- The largest iPath Pure Beta S&P GSCI-Weighted ETN seller in Q2 2014 was Tower Research Capital (TRC), an estimated $26K sold.
Based on aggregated 13F filings for Q2 2014.